Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial-Reference-Cited by-同舟云学术

Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Published:2021-04 Issue:4 Volume:9 Page:360-372
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Dixon Barry,Smith Roger J,Campbell Duncan J,Moran John L,Doig Gordon S,Rechnitzer Thomas,MacIsaac Christopher M,Simpson Nicholas,van Haren Frank M P,Ghosh Angajendra N,Gupta Sachin,Broadfield Emma J C,Crozier Timothy M E,French Craig,Santamaria John D

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference61 articles.

1. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation;Gajic;Crit Care Med,2004

2. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries;Bellani;JAMA,2016

3. Acute respiratory distress syndrome;Thompson;N Engl J Med,2017

4. Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome;Cheung;Am J Respir Crit Care Med,2006

5. One-year outcomes in survivors of the acute respiratory distress syndrome;Herridge;N Engl J Med,2003

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome Measures to Evaluate Functional Recovery in Survivors of Respiratory Failure;CHEST Critical Care;2024-09

2. The Preventive and Therapeutic Effects of Acute and Severe Inflammatory Disorders with Heparin and Heparinoid;Biomolecules;2024-08-28

3. Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial;Scientific Reports;2024-08-27

4. Inhaled heparin: Past, present, and future;Drug Discovery Today;2024-08

5. An update on the pharmacological management of acute respiratory distress syndrome;Expert Opinion on Pharmacotherapy;2024-06-12